rs121908135
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_031475.3(ESPN):c.2230G>A(p.Asp744Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000238 in 1,605,250 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00025 ( 1 hom. )
Consequence
ESPN
NM_031475.3 missense
NM_031475.3 missense
Scores
5
9
5
Clinical Significance
Conservation
PhyloP100: 9.71
Genes affected
ESPN (HGNC:13281): (espin) This gene encodes a multifunctional actin-bundling protein. It plays a major role in regulating the organization, dimensions, dynamics, and signaling capacities of the actin filament-rich, microvillus-type specializations that mediate sensory transduction in various mechanosensory and chemosensory cells. Mutations in this gene are associated with autosomal recessive neurosensory deafness, and autosomal dominant sensorineural deafness without vestibular involvement. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3732771).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESPN | NM_031475.3 | c.2230G>A | p.Asp744Asn | missense_variant | 10/13 | ENST00000645284.1 | NP_113663.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESPN | ENST00000645284.1 | c.2230G>A | p.Asp744Asn | missense_variant | 10/13 | NM_031475.3 | ENSP00000496593.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152156Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000201 AC: 47AN: 233842Hom.: 0 AF XY: 0.000189 AC XY: 24AN XY: 127082
GnomAD3 exomes
AF:
AC:
47
AN:
233842
Hom.:
AF XY:
AC XY:
24
AN XY:
127082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000255 AC: 370AN: 1453094Hom.: 1 Cov.: 32 AF XY: 0.000259 AC XY: 187AN XY: 722260
GnomAD4 exome
AF:
AC:
370
AN:
1453094
Hom.:
Cov.:
32
AF XY:
AC XY:
187
AN XY:
722260
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152156Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74308
GnomAD4 genome
AF:
AC:
12
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
25
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 20, 2018 | The p.Asp744Asn variant (rs121908135) was reported in one patient with severe bilateral sensorineural hearing loss, and transfection of this variant in epithelial cell culture resulted in about 10 times higher presence of irregular microvilli patches compared to wild-type (Donaudy 2006). This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.04 percent in the European Non-Finnish population (identified on 44 out of 117,486 chromosomes) and has been reported to the ClinVar database (Variation ID: 4421). The aspartic acid at position 744 is highly conserved and computational analyses of the effects of the p.Asp744Asn variant on protein structure and function indicate a deleterious effect (SIFT: damaging, MutationTaster: disease causing, PolyPhen-2: probably damaging). Altogether, there is not enough evidence to classify the p.Asp744Asn variant with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 25, 2024 | Observed in unrelated individuals with sensorineural hearing loss in published literature (PMID: 15930085, 33297549); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15930085, 33297549) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 25, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 744 of the ESPN protein (p.Asp744Asn). This variant is present in population databases (rs121908135, gnomAD 0.04%). This missense change has been observed in individual(s) with ESPN-related conditions (PMID: 15930085, 33297549). ClinVar contains an entry for this variant (Variation ID: 4421). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects ESPN function (PMID: 15930085). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Deafness, without vestibular involvement, autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2006 | - - |
Autosomal recessive nonsyndromic hearing loss 36;C5231434:Usher syndrome, type 1M Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 09, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T;T;T;T;.;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
M;.;M;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D;D;.;.;.;.
REVEL
Uncertain
Sift
Pathogenic
.;.;D;D;.;.;.;.
Sift4G
Uncertain
.;.;D;T;D;.;D;.
Polyphen
D;.;D;.;D;.;.;.
Vest4
0.56, 0.96, 0.95
MutPred
Gain of MoRF binding (P = 0.0567);Gain of MoRF binding (P = 0.0567);Gain of MoRF binding (P = 0.0567);.;.;.;.;.;
MVP
0.77
MPC
0.62
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at